Loading market dashboard
Fusion Pharmaceuticals Inc.
FUSNHealthcareNASDAQCA
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Fusion Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $140.11M | $140.11M - $140.11M | -$28.02M | -$0.78 | 2 |
| Dec 2027 | $18.11M | $18.11M - $18.11M | -$3.62M | -$1.588 | 3 |
| Dec 2026 | $11.07M | $11.07M - $11.07M | -$2.21M | -$1.589 | 4 |
| Dec 2025 | $542.9K | $542.9K - $542.9K | -$108.6K | -$1.603 | 3 |
| Dec 2024 | $3.97M | $247.9K - $14.17M | -$793.3K | -$1.439 | 4 |
| Dec 2023 | $2.04M | $2.04M - $2.04M | -$408.0K | -$1.426 | 3 |
| Dec 2022 | $1.25M | $1.25M - $1.25M | -$250.3K | -$1.986 | 5 |
| Dec 2021 | $707.6K | $98.6K - $2.38M | -$141.5K | -$1.972 | 6 |
| Dec 2020 | $2.00M | $278.7K - $6.72M | -$400.0K | -$2.688 | 10 |